IPO Update: 58 Drug Developers Raised $12.5bn Through Q3
With Three More In Q4, 2020 Total Reaches 61
The average return for companies that went public in the US through the end of September was 49.4% as of 5 October. The fourth quarter started with three additional initial public offerings on 1 October.
